Genomic Diversity and Drug Resistance in Plasmodium falciparum

Plasmodium falciparum exhibits remarkable genomic variation that underpins its capacity to evade host immunity and develop resistance to antimalarial drugs. High rates of mutation, frequent recombination and abundant structural polymorphisms generate a dynamic parasite population in which selective pressures from drug use and immune responses drive the emergence and spread of resistance-conferring alleles. Patterns of diversity vary geographically, reflecting local transmission intensity, human mobility and intervention strategies. Key genomic regions, such as those encoding transporters, enzymes and surface antigens, show recurrent signatures of positive selection where drug pressure is intense. Understanding the distribution and evolution of resistance markers through large-scale genomic surveillance is essential for guiding treatment policy, informing vaccine design and targeting control efforts in endemic regions.

Research from Nature Portfolio

Recent studies have demonstrated the feasibility of deploying field-ready sequencing platforms to map both resistance alleles and vaccine targets in endemic settings. In Ghana, a portable nanopore workflow applied to dried blood spots enabled rapid detection of known antimalarial resistance mutations alongside diversity profiling of the circumsporozoite protein, revealing persistent sulfadoxine-pyrimethamine resistance and confirming chloroquine susceptibility in local parasite populations. A nationwide surveillance effort in Senegal combined genetic relatedness metrics and polygenomic infection patterns to infer transmission intensity and identify clusters enriched for resistance-associated haplotypes, showing that parasites sharing drug-resistance loci formed extensive networks indicative of ongoing selection. Across Zambia, whole-genome sequencing of a representative national survey uncovered regional clustering of parasite populations and identified strong positive-selection signatures at loci linked to sulfadoxine-pyrimethamine and artemisinin combination therapies, with variation between eastern and western provinces reflecting heterogeneous drug pressure and transmission dynamics.

Genomic Diversity and Drug Resistance in Plasmodium falciparum publication trend

The graph below shows the total number of articles in genomic diversity and drug resistance in plasmodium falciparum across all publications each year (not limited to Nature Index journals).

Technical terms

Polygenomic infection: Presence of multiple genetically distinct parasite strains within a single human host.

Multiplicity of infection (MOI): Number of distinct parasite genotypes co-infecting an individual, reflecting transmission intensity.

Identity by descent (IBD): Measure of genetic relatedness indicating segments of genome inherited from a common ancestor.

Single nucleotide polymorphism (SNP): Variation at a single base position in the genome among individuals of a species.

Genomic surveillance: Continuous monitoring of pathogen genomes across time and space to track diversity, selection and resistance.

References

1. Drug resistance and vaccine target surveillance of Plasmodium falciparum using nanopore sequencing in Ghana. Nature Microbiology (2023).
2. Malaria surveillance reveals parasite relatedness, signatures of selection, and correlates of transmission across Senegal. Nature Communications (2023).
3. MOIRE: a software package for the estimation of allele frequencies and effective multiplicity of infection from polyallelic data. Bioinformatics (2024).
4. Genomics reveals heterogeneous Plasmodium falciparum transmission and selection signals in Zambia. Communications Medicine (2024).
5. Strong isolation by distance and evidence of population microstructure reflect ongoing Plasmodium falciparum transmission in Zanzibar. eLife (2024).
6. Indels, structural variation, and recombination drive genomic diversity in Plasmodium falciparum. Genome Research (2016).
7. An open dataset of Plasmodium falciparum genome variation in 7,000 worldwide samples. Wellcome Open Research (2021).